Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -11.09% is 248% below its 5-year average of -3.19%, near the low end of its 5-year range (-11.09%–-0.34%).
As of the fiscal period ended Tuesday, June 30, 2026. 94.05% below its 12-month average of -5.71%.
Reported quarterly return on assets; no daily interpolation. Q4 FY2026 (2026-06-30): -0.44%.
RETURN ON ASSETS (ROA)
-11.09%
RETURN ON ASSETS (ROA) AVG TTM
-5.71%
RETURN ON ASSETS (ROA) AVG 3Y
-4.17%
RETURN ON ASSETS (ROA) AVG 5Y
-3.19%
RETURN ON ASSETS (ROA) AVG 10Y
-3.74%
RETURN ON ASSETS (ROA) AVG 15Y
-5.20%
RETURN ON ASSETS (ROA) AVG 20Y
-4.03%
CURRENT VS TTM AVG
-94.05%
CURRENT VS 3Y AVG
-165.79%
CURRENT VS 5Y AVG
-247.83%
CURRENT VS 10Y AVG
-196.60%
CURRENT VS 15Y AVG
-113.46%
CURRENT VS 20Y AVG
-175.44%
SECTOR MEDIAN · HEALTHCARE
-30.07%
median of 666 covered companies
CURRENT VS SECTOR MEDIAN
+63.12%
vs the sector median at left
Accuray Incorporated
Market Cap
$34.54M
Return on Assets (ROA)
-11.09%
TTM Avg
-5.71%
3Y Avg
-4.17%
5Y Avg
-3.19%
Market Cap
$34.18M
Return on Assets (ROA)
-42.84%
TTM Avg
-15.31%
3Y Avg
-31.73%
5Y Avg
-29.34%
Market Cap
$34.10M
Return on Assets (ROA)
-114.53%
TTM Avg
-107.26%
3Y Avg
-84.46%
5Y Avg
-72.21%
Market Cap
$35.15M
Return on Assets (ROA)
-136.91%
TTM Avg
-90.70%
3Y Avg
-79.79%
5Y Avg
-214.88%
Market Cap
$35.52M
Return on Assets (ROA)
118.69%
TTM Avg
-31.86%
3Y Avg
-49.56%
5Y Avg
-43.59%
Market Cap
$33.05M
Return on Assets (ROA)
-190.81%
TTM Avg
-476.65%
3Y Avg
-339.92%
5Y Avg
-580.90%
Market Cap
$36.99M
Return on Assets (ROA)
-120.78%
TTM Avg
-168.59%
3Y Avg
-147.82%
5Y Avg
-131.31%
Market Cap
$36.31M
Return on Assets (ROA)
-103.00%
TTM Avg
-39.81%
3Y Avg
-17.36%
5Y Avg
-12.69%
Market Cap
$32.76M
Return on Assets (ROA)
-277.36%
TTM Avg
-524.61%
3Y Avg
-478.10%
5Y Avg
-316.43%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Accuray Incorporated (ARAY) | $34.54M | -11.09% | -5.71% | -4.17% | -3.19% |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.18M | -42.84% | -15.31% | -31.73% | -29.34% |
| Aligos Therapeutics, Inc. (ALGS)vs › | $34.10M | -114.53% | -107.26% | -84.46% | -72.21% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.15M | -136.91% | -90.70% | -79.79% | -214.88% |
| Elutia Inc (ELUT)vs › | $35.52M | 118.69% | -31.86% | -49.56% | -43.59% |
| HeartBeam, Inc. (BEAT)vs › | $33.05M | -190.81% | -476.65% | -339.92% | -580.90% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.99M | -120.78% | -168.59% | -147.82% | -131.31% |
| DocGo Inc. (DCGO)vs › | $36.31M | -103.00% | -39.81% | -17.36% | -12.69% |
| EUDA Health Holdings Limited (EUDA)vs › | $32.76M | -277.36% | -524.61% | -478.10% | -316.43% |
| Edesa Biotech, Inc. (EDSA)vs › | $36.99M | -110.85% | -107.44% | -115.17% | -101.88% |
ROA
-11.1%
ROE
-118.0%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-06-30 | -11.09% |
| 2025-06-30 | -0.34% |
| 2024-06-30 | -3.32% |
| 2023-06-30 | -1.94% |
| 2022-06-30 | -1.13% |
| 2021-06-30 | -1.31% |
| 2020-06-30 | 0.78% |
| 2019-06-30 | -3.75% |
| 2018-06-30 | -6.31% |
| 2017-06-30 | -7.28% |
| 2016-06-30 | -5.44% |
| 2015-06-30 | -8.56% |
| 2014-06-30 | -7.16% |
| 2013-06-30 | -21.69% |
| 2012-06-30 | -15.23% |
| 2011-06-30 | -5.85% |
| 2010-06-30 | 1.08% |
| 2009-06-27 | 0.22% |
| 2008-06-28 | 1.82% |
| 2007-06-30 | -1.69% |
| 2006-06-30 | -24.31% |
| 2005-06-30 | -29.00% |
| 2004-06-30 | 0.00% |
| 2003-06-30 | -48.97% |
| 2002-06-30 | -48.61% |
